The EPS projection of Hologic, Inc. (NASDAQ:HOLX) for period quarter completed 2016-12-31 is $0.51.
The EPS estimates given a week and 30-days ago were $0.51 and $0.51 correspondingly. This number 60 and 90 days before was $0.51 and $0.51 respectively. However, over last week ago, the change in EPS estimate is 0%.
For the quarter completed 3 mean estimate is $0.51 based on 11 EPS estimations. As on 2016-07-27 estimated EPS stood at $0.51 showing surprise of $0.04, or 8.51%. Following the disclosed forecasts, the standard deviation is $0.01.
The upgrade in EPS revisions were 0 a week earlier against negative revisions of 1. In last 1- month and 60-days, the upgrade in EPS revisions were 1 and 1 correspondingly, whereas for a quarter and 120-days earlier, it was 5 and 5 in that sequence.
The negative revisions of earnings per-share in the last 1-month and 60-days were 1 and 1 in that order. However, a quarter and 120-days earlier, this count was 0 and 0 correspondingly.
EPS revisions downgrade and upgrade in the last 18 days were 1 and 4, correspondingly.
Quarterly Sales Estimates
The arithmetic mean of apparent annual sales of Hologic, Inc. (NASDAQ:HOLX) is $759.086 and the median is $754.6. The estimate is stated by 3 analysts for the fiscal 2017.
The highest yearly projection is $768.5 and lowest sales mark is $754.16. This results a standard deviation of $8.155.
Almost 3 have revised sales target positively in the past week and 3 have downgraded forecasts. Depending on the stated estimates, the calculated change in target against the past week is -0.294%.
Nearly 3 revised sales projections positively over the past month and 3 have downgraded forecasts. It leads to a mean estimate deviation of -0.294%.
Just about 3 have revised sales forecast positively over the quarter and 3 have downgraded forecasts, giving a deviation of -0.642%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...